Influenza-like illness, the time to seek healthcare, and influenza antiviral receipt during the 2010-2011 influenza season - United States

Journal of Infectious Diseases

Volumn 210, Issue 4, 2014, Pages 535-544

  Biggerstaff, Matthew ^a   Jhung, Michael A ^a   Reed, Carrie ^a   Fry, Alicia M ^a   Balluz, Lina ^b   Finelli, Lyn ^a  

^a Epidemiology and Prevention Branch Influenza Division National Center for Immunization and Respiratory Disease   (Canada)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Healthcare seeking behavior; Influenza; Influenza antiviral treatment; Time to seek healthcare

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; HEALTH STATUS; HEART DISEASE; HELP SEEKING BEHAVIOR; HIGH RISK PATIENT; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SEASONAL INFLUENZA; SELF REPORT; TREND STUDY; UNITED STATES;

HEALTHCARE-SEEKING BEHAVIOR; INFLUENZA; INFLUENZA ANTIVIRAL TREATMENT; TIME TO SEEK HEALTHCARE;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SEASONS; UNITED STATES; YOUNG ADULT;

EID: 84905572896     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu224     Document Type: Article

References (27)

1. Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 2011; 60: 1-24.
2. Brammer L, Blanton L, Epperson S, et al. Surveillance for influenza during the 2009 influenza A (H1N1) pandemic-United States, April 2009-March 2010. Clin Infect Dis 2011; 52 (Suppl 1): S27-35.
3. Centers for Disease Control and Prevention. Update: influenza activity- United States, 2010-11 season, and composition of the 2011-12 influenza vaccine. MMWR Morb Mortal Wkly Rep 2011; 60: 705-12.
4. Hsieh YH, Kelen GD, Dugas AF, Chen KF, Rothman RE. Emergency physicians' adherence to Centers for Disease Control and Prevention guidance during the 2009 influenza A H1N1 pandemic. West J Emerg Med 2013; 14: 191-9.
5. Vijayan V, Jing J, Zangwill KM. Evaluation of diagnostic and therapeutic approaches for suspected influenza A(H1N1)pdm09 infection, 2009-2010. Emerg Infect Dis 2012; 18: 1414-21.
6. Biggerstaff M, Jhung M, Kamimoto L, Balluz L, Finelli L. Self-reported influenza-like illness and receipt of influenza antiviral drugs during the 2009 pandemic, United States, 2009-2010. Am J Public Health 2012; 102: e21-6.
7. Biggerstaff M, Jhung MA, Reed C, et al. Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010. Epidemiol Infect 2013: 1-12.
8. Chowdhury PP, Balluz L, MurphyW, et al. Surveillance of certain health behaviors among states and selected local areas-United States, 2005. MMWR Surveill Summ 2007; 56: 1-160.
9. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Operational and User's Guide 2012. ftp: //ftp.cdc.gov/ pub/Data/Brfss/userguide.pdf. Accessed 2 October 2012.
10. Food and Drug Administration. Tamiflu (oseltamivir phosphate) capsules label. http: //www.accessdata.fda.gov/drugsatfda-docs/label/2011/ 021087s057lbl.pdf. Accessed 21 January 2014.
11. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Statistical Notes 2001; 20: 1-10.
12. Miller EK, Griffin MR, Edwards KM, et al. Influenza burden for children with asthma. Pediatrics 2008; 121: 1-8.
13. Hirota Y, Takeshita S, Ide S, et al. Various factors associated with the manifestation of influenza-like illness. Int J Epidemiol 1992; 21: 574-82.
14. Gordon A, Ortega O, Kuan G, et al. Prevalence and seasonality of influenza- like illness in children, Nicaragua, 2005-2007. Emerg Infect Dis 2009; 15: 408-14.
15. Kropp RY, Bogaert LE, Barber R, et al. Pandemic (H1N1) 2009 outbreak at Canadian Forces cadet camp. Emerg Infect Dis 2010; 16: 1986-9.
16. Smolderen KG, Vingerhoets AJ, Croon MA, Denollet J. Personality, psychological stress, and self-reported influenza symptomatology. BMC Public Health 2007; 7: 339.
17. Currier M, Coffman T, Boyd P, Fremd B, Israel E. Influenza vaccine efficacy in a Maryland nursing home. Md Med J 1988; 37: 781-3.
18. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLOS One 2009; 4: e6051.
19. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007; 45: 1568-75.
20. Kamimoto L, Euler GL, Lu PJ, et al. Seasonal influenza morbidity estimates obtained from telephone surveys, 2007. Am J Public Health 2013; 103: 755-63.
21. Fiore AE, Shay DK, Broder K, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. Morb Mortal Wkly Rep 2008; 57: 1-60.
22. Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. 2012. http: //www. cdc.gov/h1n1flu/recommendations.htm. Accessed 2 October 2012.
23. Carrasco LR, Jit M, Chen MI, Lee VJ, Milne GJ, Cook AR. Trends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocol. Emerg Themes Epidemiol 2013; 10: 3.
24. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167: 775-85.
25. Shu B, Wu KH, Emery S, et al. Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus. J Clin Microbiol 2011; 49: 2614-9.
26. Centers for Disease Control and Prevention. Evaluation of 11 commercially available rapid influenza diagnostic tests-United States, 2011- 2012. MMWR Morb Mortal Wkly Rep 2012; 61: 873-6.
27. Centers for Disease Control and Prevention. Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates. MMWR Morb Mortal Wkly Rep 2012; 61: 410-3.